List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 767 studies with search of: hodgkins disease
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
Condition: Hodgkin's Disease
Intervention: Drug: I-131 Tositumomab therapeutic regimen
2 Recruiting Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial
Conditions: Hodgkin's Disease;   Lymphoma
Intervention:
3 Recruiting Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
Conditions: Lymphoma;   Lymphoma, Hodgkin Disease;   Hodgkin Disease
Interventions: Drug: Gemcitabine;   Drug: Vinorelbine;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cyclophosphamide;   Procedure: Autologous hematopoietic stem cell transplantation.
4 Completed Mantle Irradiation for Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Procedure: Mantle irradiation
5 Not yet recruiting Study Comparing Rituximab and a Combination of ABVD in Hodgkin's Disease
Condition: Hodgkin's Disease
Interventions: Drug: Rituximab;   Drug: ABVD
6 Recruiting Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease
Conditions: Breast Cancer;   Hodgkin's Disease
Interventions: Procedure: breast MRI;   Procedure: Mammogram
7 Active, not recruiting A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
Conditions: Pediatric;   Hodgkin's Disease
Interventions: Drug: COPP/ABV;   Drug: intensive chemo with concurrent growth factor
8 Recruiting Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide (Revlimid®)
9 Completed Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
Conditions: HIV Infections;   Hodgkin's Disease
Interventions: Drug: Vinblastine sulfate;   Drug: Dacarbazine;   Drug: Filgrastim;   Drug: Bleomycin sulfate;   Drug: Doxorubicin hydrochloride
10 Completed Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)
Condition: Hodgkin's Disease
Interventions: Drug: Methotrexate;   Drug: Leucovorin calcium;   Drug: 6-Thioguanine
11 Recruiting Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma
Condition: Hodgkin's Lymphoma
Intervention: Drug: Temsirolimus
12 Recruiting Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade
Conditions: Hodgkin's Disease;   Malignant Lymphomas High Grade;   Chemoresistance
Intervention: Procedure: TEP au MIBI
13 Active, not recruiting Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: ABVD regimen;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vinblastine;   Procedure: peripheral blood stem cell transplantation
14 Active, not recruiting Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: ABVD regimen;   Drug: Stanford V regimen;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: mechlorethamine hydrochloride;   Drug: prednisone;   Drug: vinblastine;   Drug: vincristine sulfate;   Radiation: radiation therapy
15 Active, not recruiting Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma;   Lymphoma
Interventions: Drug: Bortezomib;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Ifosfamide;   Drug: Mesna
16 Terminated
Has Results 		Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease
Conditions: Hodgkin's Disease;   Lymphoma
Intervention: Drug: Alemtuzumab (Campath-1H)
17 Active, not recruiting Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: prednisone;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Radiation: radiation therapy
18 Recruiting Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma
Conditions: Lymphoma;   Neurotoxicity
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: prednisolone;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Radiation: radiation therapy
19 Active, not recruiting Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: ABVD regimen;   Drug: chlorambucil;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: prednisolone;   Drug: procarbazine hydrochloride;   Drug: vinblastine;   Drug: vincristine sulfate;   Radiation: radiation therapy
20 Recruiting Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease
Condition: Lung Cancer
Intervention: Procedure: chest computed tomography scan

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services